HealthyNCT05073016
The Effect of Intermittent Theta Burst Stimulation on Motor Learning in Healthy Adults
A study testing neuromodulation and motor learning training in people with Healthy, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).
Trial summary
This study investigates the effect of different application frequencies of intermittent theta burst stimulation on motor learning in healthy adults. Read more about this study
- Who is it for?
- Ages 40 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- neuromodulation and motor learning training
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Nov 2021to 5 Feb 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- being at the age of 40-75 years
Who cannot join
- visual disability
- cognitive or psychiatric problems such as dementia, depression, etc.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
İstanbul Bakırköy Ruh ve Sinir Hastalıkları Hastanesi
Istanbul
About this study
This study investigates the effect of different application frequencies of intermittent theta burst stimulation on motor learning in healthy adults.
- Conditions
- Healthy
- Being tested
- neuromodulation, motor learning training
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
neuromodulationOther
neuromodulation: Neuromodulation is technology that acts directly upon nerves. It is the alteration-or modulation-of nerve activity by delivering electrical or magnetic stimulus/current.
motor learning trainingOther
motor learning training requires performing a sequential training called finger taping task
| Study group | Role | What they receive |
|---|---|---|
| Finger Taping Task + iTBS intermittent group | Active comparator | Finger Taping Task + iTBS Daily application group: the group receives these applications every other day for 5 sessions. Receives: Other: neuromodulation |
| Finger Taping Task intermittent Group | Active comparator | Finger Taping Task intermittent application group: the group receives the application every other day for 5 sessions. Receives: Other: motor learning training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Finger Taping Task
The total right answers and the mean response time in the finger taping task will be recorded
Measured: 5 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Oct 2021
- Study start1 Nov 2021
- Primary completion4 Feb 2022
- Study completion5 Feb 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Care provider
- Enrolment
- 10 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul Medeniyet University
- Sponsor type
- University, hospital or other
- Collaborators
- Istanbul University - Cerrahpasa
- Responsible party
- Principal investigator, Esma Nur KOLBAŞI, Istanbul Medeniyet University
- Investigators
- Burcu Ersöz Hüseyinsinoğlu, PhD, Study director, Istanbul University - Cerrahpasa
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05073016
- Sponsor's protocol ID
- IstanbulMU21
- Status last verified
- Feb 2022
- First submitted
- 7 Oct 2021
- Last updated
- 2 Mar 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Mar 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Intermittent Theta Burst Stimulation on Motor Learning in Healthy Adults
- ClinicalTrials.gov ID
- NCT05073016
- Acronym / sponsor ID
- IstanbulMU21
- Conditions
- Healthy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 10 participants (actual)
- Lead sponsor
- Istanbul Medeniyet UniversityUniversity, hospital or other
- Collaborators
- Istanbul University - Cerrahpasa
- Study start
- 1 Nov 2021 (actual)
- Primary completion
- 4 Feb 2022 (actual)
- Study completion
- 5 Feb 2022 (actual)
- First posted
- 11 Oct 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates the effect of different application frequencies of intermittent theta burst stimulation on motor learning in healthy adults.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, care provider)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Finger Taping Task + iTBS intermittent group | Active comparator | Other: neuromodulationFinger Taping Task + iTBS Daily application group: the group receives these applications every other day for 5 sessions. |
| Finger Taping Task intermittent Group | Active comparator | Other: motor learning trainingFinger Taping Task intermittent application group: the group receives the application every other day for 5 sessions. |
Who may qualify
- Ages
- 40 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- being at the age of 40-75 years
Key exclusion criteria (2 listed)
- visual disability
- cognitive or psychiatric problems such as dementia, depression, etc.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| neuromodulationneuromodulation: Neuromodulation is technology that acts directly upon nerves. It is the alteration-or modulation-of nerve activity by delivering electrical or magnetic stimulus/current. | Other | Finger Taping Task + iTBS intermittent group |
| motor learning trainingmotor learning training requires performing a sequential training called finger taping task | Other | Finger Taping Task intermittent Group |
Primary outcome
Finger Taping Task
Time frame: 5 minutes
The total right answers and the mean response time in the finger taping task will be recorded
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Mar 2022.
- Individual participant dataSharing planned: No
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Burcu Ersöz Hüseyinsinoğlu, PhD study director
Istanbul University - Cerrahpasa
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing neuromodulation and motor learning training in people with Healthy, run by Istanbul Medeniyet University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Finger Taping Task (time frame: 5 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Mar 2022; AzTrials last refreshed its copy on 7 Nov 2026.